Related Experiment Video
Updated: Jan 11, 2026
10:09
Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
7.2K
Extracellular Vesicles Profiling in Acute Myeloid Leukemia Cell Lines: A Proteomic Characterization.
Beatrice Dufrusine1,2, Maria Concetta Cufaro2,3, Alice Di Sebastiano2
1Department of Bioscience and Technology for Food Agriculture and Environment, University of Teramo, 64100 Teramo, Italy.
Cells
|November 13, 2025
Summary
Extracellular vesicles (EVs) from acute myeloid leukemia (AML) cells were analyzed for their protein content. This proteomic profiling identified key molecules and pathways involved in cancer progression and drug resistance.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Extracellular vesicles (EVs) mediate cell-to-cell communication and are implicated in cancer progression and drug resistance.
- EVs play a role in the bone marrow microenvironment, influencing hematopoietic stem cell fate, which is crucial in acute myeloid leukemia (AML).
Purpose of the Study:
- To proteomically profile EVs derived from three distinct AML cell lines.
- To identify EV-associated proteins and pathways that may contribute to AML pathogenesis, progression, and therapeutic resistance.
Main Methods:
- Proteomic analysis of EVs isolated from OCI-AML-2, OCI-AML-3, and HL-60 cell lines.
- Gene Ontology enrichment analysis to categorize identified proteins.
- Network modeling to reveal modulated pathways within EV protein cargo.
Main Results:
- Identified a significant enrichment of proteins within the 'Extracellular Exosome' Gene Ontology category.
- Network analysis revealed modulated pathways related to inflammation activation and metastatic processes in AML-derived EVs.
- The proteomic profiles provided insights into EV-associated molecules impacting cancer progression.
Conclusions:
- Proteomic profiling of AML cell-derived EVs is a valuable approach to identify molecules and pathways relevant to cancer progression and drug resistance.
- Understanding EV composition can elucidate mechanisms of AML development and therapeutic challenges.
